Literature DB >> 2545025

Avian cells expressing the Newcastle disease virus hemagglutinin-neuraminidase protein are resistant to Newcastle disease virus infection.

T G Morrison1, L W McGinnes.   

Abstract

The cDNA derived from the Newcastle disease virus (NDV) hemagglutinin-neuraminidase (HN) gene was inserted into a replication-competent Schmidt-Ruppin Rous sarcoma virus-derived vector. Chick embryo cells transfected with this vector expressed HN-sized protein which could be precipitated with anti-HN antibody. These cells adsorbed avian red blood cells and the cell surfaces exhibited neuraminidase activity while cells transfected with an antisense version of the gene were negative for hemadsorption and neuraminidase. The cells transfected with the retroviral vector containing the HN gene were resistant to infection by NDV and influenza virus, viruses which bind to sialic acid containing receptors, but sensitive to vesicular stomatitis virus (VSV). Cells transfected with the antisense version of the HN gene were sensitive to NDV, influenza virus, and VSV infection. Thus the HN protein-expressing cells are likely resistant to NDV and influenza virus due to the destruction of the cellular receptors by the neuraminidase of the HN protein. The expression of the influenza virus HA protein using the same retrovirus vector has been reported previously (L. A. Hunt, D. W. Brown, H. L. Robinson, C. W. Naeve, and R. G. Webster, 1988, J. Virol. 62, 3014-3019). Cells infected with this vector were sensitive to infection with influenza virus, NDV, and VSV. Thus expression of a viral surface protein does not necessarily confer resistance of the cell to the homologous virus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2545025     DOI: 10.1016/0042-6822(89)90505-9

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  19 in total

1.  Probing the sialic acid binding site of the hemagglutinin-neuraminidase of Newcastle disease virus: identification of key amino acids involved in cell binding, catalysis, and fusion.

Authors:  Helen Connaris; Toru Takimoto; Rupert Russell; Susan Crennell; Ibrahim Moustafa; Allen Portner; Garry Taylor
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Role of the hemagglutinin-neuraminidase protein in the mechanism of paramyxovirus-cell membrane fusion.

Authors:  Toru Takimoto; Garry L Taylor; Helen C Connaris; Susan J Crennell; Allen Portner
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Mechanism of interference mediated by human parainfluenza virus type 3 infection.

Authors:  M A Horga; G L Gusella; O Greengard; N Poltoratskaia; M Porotto; A Moscona
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Evidence that Receptor Destruction by the Sendai Virus Hemagglutinin-Neuraminidase Protein Is Responsible for Homologous Interference.

Authors:  Hideo Goto; Keisuke Ohta; Yusuke Matsumoto; Natsuko Yumine; Machiko Nishio
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

5.  Neuraminidase-deficient Sendai virus HN mutants provide protection from homologous superinfection.

Authors:  Christine A Baumann; Wolfgang J Neubert
Journal:  Arch Virol       Date:  2009-12-19       Impact factor: 2.574

6.  Mutational analysis of heptad repeats in the membrane-proximal region of Newcastle disease virus HN protein.

Authors:  J Stone-Hulslander; T G Morrison
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

7.  Assembly and biological and immunological properties of Newcastle disease virus-like particles.

Authors:  Lori W McGinnes; Homer Pantua; Jason P Laliberte; Kathryn A Gravel; Surbhi Jain; Trudy G Morrison
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

8.  Disulfide bond formation is a determinant of glycosylation site usage in the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus.

Authors:  L W McGinnes; T G Morrison
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

Review 9.  Virological and Immunological Outcomes of Coinfections.

Authors:  Naveen Kumar; Shalini Sharma; Sanjay Barua; Bhupendra N Tripathi; Barry T Rouse
Journal:  Clin Microbiol Rev       Date:  2018-07-05       Impact factor: 26.132

10.  Complementation between avirulent Newcastle disease virus and a fusion protein gene expressed from a retrovirus vector: requirements for membrane fusion.

Authors:  T Morrison; C McQuain; L McGinnes
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.